Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 3, 2009, Pages 317-318

  Muthusami, Sunil ^a   Basu, Sriparna ^a   Kumar, Ashok ^a   Dash, Amitabh ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; DIPHENHYDRAMINE; ESCITALOPRAM; RABEPRAZOLE;

ANXIETY DISORDER; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFECT; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; HUMAN; LETTER; MALE; MUSCLE HYPERTONIA; RETROSTERNAL PAIN; SCHOOL CHILD; STUTTERING; SYMPTOM; TREMOR;

ACUTE DISEASE; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANXIETY; BASAL GANGLIA DISEASES; CHEST PAIN; CHILD; CITALOPRAM; DYSKINESIA, DRUG-INDUCED; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 67650914248     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0134     Document Type: Letter

References (12)

1. Birmes P, Coppin D, Schmitt L, Lauque D: Serotonin syndrome:A brief review. CMAJ 168:1439-1442, 2003.
2. Huska MT, Catalano G, Catalano MC: Serotonin syndrome associated with the use of escitalopram. CNS Spectr 12:270-274, 2007.
3. Isolan L, Pheula G, Salum GA, Jr., Oswald S, Rohde LA, Manfro GG: An open-label trial of escitalopram in children and adolescents with social anxiety disorder. J Child Adolesc Psychopharmacol17:751-760, 2007.
4. Kul M, Kilincaslan A, Yumru M, Kandemir H, Adaletli H, Ceylan MF: Escitalopram-associated mania in a child. J ChildAdolesc Psychopharmacol 18:119-120, 2008.
5. LoVecchio F, Watts D, Winchell J, Knight J, McDowellT: Outcomes after supratherapeutic escitalopram ingestions. J EmergMed 30:17-19, 2006.
6. Patel OP, Simon MR: Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine. IntArch Allergy Immunol 140:27-29, 2006.
7. Pedro JGR, Iria C, Garcia BP, Pablo C: Escitalopram-inducedparoxysmal dystonia. Clin Neuropharmacol 30:124-126, 2007.
8. Safer DJ: Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?Pediatrics 118:1248-1251, 2006.
9. Schillevoort I, van Puijenbroek EP, de Boer A: Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: A case-control study using spontaneous reports. IntClin Psychopharmacol 17:75-79, 2002.
10. Stahl SM: Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd ed, Drug Combinations in Panic Attack. New York: Cambridge University Press, 2000, p 355.
11. Vari G, Beckson M: Escitalopram-associated serotonin toxicity.J Clin Psychopharmacol 27:229-230, 2007.
12. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K: A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45:280-288, 2006